• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Insulet touts full market launch of mobile apps for Omnipod Dash

August 9, 2019 By Sarah Faulkner

Insulet's Omnipod Dash systemInsulet (NSDQ:PODD) touted the full market launch of the Omnipod Display and Omnipod View apps for people using the company’s Omnipod Dash system.

The Display app enables users to display data from their Personal Diabetes Manager device onto their smartphones. The View app gives caregivers and family members the option to remotely monitor Omnipod Dash system data, according to Insulet.

Both apps are available to download via the iOS app store.

“The Omnipod Dash mobile apps and widget capability are the first of their kind when it comes to monitoring insulin pump data and we are excited to bring this combined view of insulin delivery and Dexcom CGM data to our users,” chief commercial officer Bret Christensen said in prepared remarks. “People look at their mobile phone countless times throughout the day and now Omnipod Dash users are able to conveniently and discreetly check their diabetes status or that of their loved ones’, in order to stay well-informed, help make diabetes management decisions, and make diabetes a smaller part of life.”

Earlier this week, Insulet reported its second-quarter financial results. The company missed the consensus estimates on Wall Street, but raised its outlook for the rest of the year.

Insulet posted profits of $1.4 million or $0.02 per share, on sales of $177.1 million for the three months ended June 30, for a bottom-line gain of 182% and sales growth of 42.5% compared with the same time last year.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, mHealth (Mobile Health), Pharmaceuticals, Wall Street Beat Tagged With: Insulet

IN CASE YOU MISSED IT

  • Embecta stock soars on first full-quarter results after BD spinoff
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
  • Study backs Fluidx embolic device for vessel filling
  • Senseonics stock is up as it sticks by revenue guidance

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS